Drugs / RNA CART123
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02623582 | Dec 2015 → Aug 2016 | acute myeloid leukemia | University of Pennsylvania | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RNA CART123 | “Pilot open-label study to estimate the feasibility, safety and efficacy of intravenously administered, RNA electroporated autologous T cells expressing anti-CD123 chimeric...” NCT02623582 ↗ |
| Modality | Cell therapy | “RNA electroporated autologous T cells expressing anti-CD123 chimeric antigen receptors” NCT02623582 ↗ |
| Route | Intravenous | “Given IV” NCT02623582 ↗ |